Showing results (101-110 of 239) with videos related to

Sort By:
Pageof 24
Cancer Chemotherapy and Pharmacology|January 1, 1983
Time dependency of adriamycin and adriamycinol kineticsP Gil, R Favre, A Durand, et al.
International Journal of Cancer|October 7, 1998
Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumorM Baciuchka, M Remacle-Bonnet, F Garrouste, et al.
Journal of Structural Biology|October 17, 1998
Immuno-cross-reactivity of CUT-1 and cuticlin epitopes between ascaris lumbricoides, Caenorhabditis elegans, and HeterorhabditisR Favre, M Cermola, C P Nunes, et al.
Bulletin Du Cancer|January 1, 1988
[Pharmacokinetics in phase IV studies for the preview of a therapeutic protocol]R Favre, M Charbit, Y Rinaldi, et al.
Annales De Medecine Interne|January 1, 1989
[Comparative study of 3 successive treatment protocols of osteogenic osteosarcoma in children, adolescents and young adults. Apropos of 100 cases]N Delepine, J C Desbois, G Delepine, et al.
Molecular Plant-Microbe Interactions : MPMI|October 12, 1999
The Rhizobium etli trpB gene is essential for an effective symbiotic interaction with Phaseolus vulgarisR Taté, A Riccio, E Caputo, et al.
Molecular Plant-Microbe Interactions : MPMI|June 30, 2000
Nodule invasion and symbiosome differentiation during Rhizobium etli-Phaseolus vulgaris symbiosisM Cermola, E Fedorova, R Taté, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1995
[Gastroschisis. Management. 50 cases]F Becmeur, M Dreyfus, B Langer, et al.
Journal of Clinical Pharmacy and Therapeutics|July 24, 2004
A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activityJ Ciccolini, C Mercier, M-F Blachon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2012
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysisM Montemurro, H Gelderblom, U Bitz, et al.
Pageof 24